- Home
- BNR vs SXTC Comparison
BNR vs SXTC Comparison
Compare BNR & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- SXTC
- Stock Information
- Founded
- BNR 2014
- SXTC 2005
- Country
- BNR China
- SXTC China
- Employees
- BNR 674
- SXTC N/A
- Industry
- BNR Medical Specialities
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- SXTC Health Care
- Exchange
- BNR Nasdaq
- SXTC Nasdaq
- Market Cap
- BNR 38.3M
- SXTC 34.4M
- IPO Year
- BNR 2020
- SXTC 2019
- Fundamental
- Price
- BNR $4.22
- SXTC $1.78
- Analyst Decision
- BNR
- SXTC
- Analyst Count
- BNR 0
- SXTC 0
- Target Price
- BNR N/A
- SXTC N/A
- AVG Volume (30 Days)
- BNR 29.7K
- SXTC 65.1K
- Earning Date
- BNR 08-21-2025
- SXTC 01-01-0001
- Dividend Yield
- BNR N/A
- SXTC N/A
- EPS Growth
- BNR N/A
- SXTC N/A
- EPS
- BNR N/A
- SXTC 20.77
- Revenue
- BNR $72,112,038.00
- SXTC $1,818,404.00
- Revenue This Year
- BNR $136.32
- SXTC N/A
- Revenue Next Year
- BNR N/A
- SXTC N/A
- P/E Ratio
- BNR N/A
- SXTC $0.08
- Revenue Growth
- BNR 0.53
- SXTC 6.78
- 52 Week Low
- BNR $2.18
- SXTC $0.95
- 52 Week High
- BNR $7.90
- SXTC $11.92
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- SXTC 47.56
- Support Level
- BNR $3.06
- SXTC $1.69
- Resistance Level
- BNR $3.50
- SXTC $1.79
- Average True Range (ATR)
- BNR 0.21
- SXTC 0.12
- MACD
- BNR 0.05
- SXTC -0.01
- Stochastic Oscillator
- BNR 95.65
- SXTC 20.44
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.